BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31528921)

  • 1. Microdistribution and quantification of the boron neutron capture therapy drug BPA in primary cell cultures of human glioblastoma tumour by NanoSIMS.
    Aldossari S; McMahon G; Lockyer NP; Moore KL
    Analyst; 2019 Nov; 144(21):6214-6224. PubMed ID: 31528921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S; Ahmad T; Barth RF; Kabalka GW
    J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S; Tjarks W; Lorey DR; Barth RF
    J Microsc; 2008 Jan; 229(Pt 1):92-103. PubMed ID: 18173648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
    Bergenheim AT; Capala J; Roslin M; Henriksson R
    J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-Phenylalanine preloading reduces the (10)B(n, α)(7)Li dose to the normal brain by inhibiting the uptake of boronophenylalanine in boron neutron capture therapy for brain tumours.
    Watanabe T; Tanaka H; Fukutani S; Suzuki M; Hiraoka M; Ono K
    Cancer Lett; 2016 Jan; 370(1):27-32. PubMed ID: 26455769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
    Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
    J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy.
    Wada Y; Hirose K; Harada T; Sato M; Watanabe T; Anbai A; Hashimoto M; Takai Y
    J Radiat Res; 2018 Mar; 59(2):122-128. PubMed ID: 29315429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: in vitro studies on human glioblastoma T98G cells.
    Chandra S; Lorey II DR; Smith DR
    Radiat Res; 2002 Jun; 157(6):700-10. PubMed ID: 12005550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boron phenyl alanine targeted chitosan-PNIPAAm core-shell thermo-responsive nanoparticles: boosting drug delivery to glioblastoma in BNCT.
    Soleimanbeigi M; Dousti F; Hassanzadeh F; Mirian M; Varshosaz J; Kasesaz Y; Rostami M
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1607-1623. PubMed ID: 35060826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of boron-10 in soft tissue by dynamic secondary ion mass spectrometry.
    Oyedepo AC; Brooke SL; Heard PJ; Day JC; Allen GC; Patel H
    J Microsc; 2004 Jan; 213(1):39-45. PubMed ID: 14678511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy.
    Elowitz EH; Bergland RM; Coderre JA; Joel DD; Chadha M; Chanana AD
    Neurosurgery; 1998 Mar; 42(3):463-8; discussion 468-9. PubMed ID: 9526978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells.
    Yoshimoto M; Kurihara H; Honda N; Kawai K; Ohe K; Fujii H; Itami J; Arai Y
    Nucl Med Biol; 2013 Jul; 40(5):625-9. PubMed ID: 23557719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
    Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y
    Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological evaluation of boronated unnatural amino acids as new boron carriers.
    Kabalka GW; Yao ML; Marepally SR; Chandra S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S374-9. PubMed ID: 19398346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the applicability of [
    Grunewald C; Sauberer M; Filip T; Wanek T; Stanek J; Mairinger S; Rollet S; Kudejova P; Langer O; Schütz C; Blaickner M; Kuntner C
    Nucl Med Biol; 2017 Jan; 44():83-89. PubMed ID: 27837726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
    Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.